Vietnam warns of food supply disruptions as African swine fever spreads
African swine fever outbreaks
are spreading in Vietnam, threatening to disrupt food supplies in the Southeast Asian country, the government warned on Friday.
Vietnam has this year detected 514 outbreaks in 28 out of 34 cities and provinces nationwide, the government said in a statement, adding that the authorities have culled more than 30,000 infected pigs.
"The risk of African swine fever is on a rising trend, negatively affecting the pig farming industry, food supplies and the environment," the government said.
African swine fever has disrupted the global pork market for years. In the worst outbreak over 2018-19, about half the domestic pig population died in China, the world's biggest producer, causing losses estimated at over $100 billion.
The recent outbreaks in Vietnam have prompted Prime Minister Pham Minh Chinh to send an urgent directive to provinces and government agencies this week to deploy measures to curb the disease.
Vietnam in 2023 approved the domestic commercial use of its first home-grown African swine fever vaccines, but officials said the rate of vaccinated pigs remains low.
"Only around 30% of the pigs in my province have been vaccinated," said an animal health official of Quang Ngai province, where infections have been reported over the past few weeks.
"It's not clear why the rate is low - it could either be the issue of vaccine availability, efficiency or cost," said another provincial official, who declined to be named as the person is not authorised to speak to the media.
The agriculture ministry's Department of Animal Health didn't respond to Reuters' request for comment. Calls to AVAC Vietnam JSC, the country's main African swine fever vaccine producer, went unanswered.
AVAC said last month it had sold 3 million vaccine doses in the domestic market and exported 600,000 doses to the Philippines and Indonesia.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
8 hours ago
- Hindustan Times
New COVID variant Stratus haunting US: What are the symptoms? Here's all you need to know
One COVID variant, 'Stratus', that has become increasingly popular in the United States during this summer and is being widely monitored by health professionals. The Stratus variant (XFG) of COVID-19 is now the third most common in the U.S., with a 14% share of cases. REUTERS/Michele Tantussi/File Photo(REUTERS) Known officially as XFG, the variant was first detected in Southeast Asia back in January. For months, it flew under the radar in the States, barely any reported cases. However, Centers for Disease Control and Prevention (CDC) detailed XFG accounted for 14% of all U.S. cases by late June, making it the third most common variant in circulation. The World Health Organization (WHO) has added XFG to its monitoring list but describes the variant's global public health risk as 'low.' The good news: WHO says that current COVID-19 vaccines are still 'expected to remain effective to this variant against symptomatic and severe disease.' ALSO READ| New COVID variant bizarre symptoms: What treatments are available and how you can protect yourself What is Stratus (XFG) and how is it different? XFG is a recombinant strain, meaning it's a blend of two earlier variants: F.7 and LP.8.1.2 (the latter is now the second most common strain in the U.S.). So, what makes XFG different? Scientists say it may have mutations that help it dodge the immune system more easily. But that doesn't mean it spreads faster. 'There is currently no clear evidence that XFG causes more severe disease or significantly different symptoms than earlier Omicron variants,' Dr. Subhash Verma, professor of microbiology and immunology at the University of Nevada, Reno. told USA Today. 'Importantly, there are no immediate public health concerns associated with this variant.' How fast is Stratus (XFG) spreading? While it hasn't overtaken the top two variants, XFG made up 0% of U.S. cases in March, climbed to 2% in April, 6% in May, and 14% by late June, according to the CDC. WHO reported a similar spike globally, from 7.4% of cases in early May to 22.7% by the end of June across 38 countries. ALSO READ| Moderna to cut 10% global staff as Covid vaccine sales keep falling What are the symptoms? The CDC continues to list common COVID symptoms such as: Fever or chills Cough Fatigue Sore throat Loss of taste or smell Congestion Muscle aches Shortness of breath Headache Nausea or vomiting
Hindustan Times
10 hours ago
- Hindustan Times
RFK Jr. pulls $500mn in funding for development of thimerosal-free flu vaccines
The Department of Health and Human Services will cancel contracts and pull funding for some vaccines that are being developed to fight respiratory viruses like COVID-19 and the flu. Robert F Kennedy Jr. has pulled back recommendations around the COVID-19 shots, fired the panel that makes vaccine recommendations, and refused to offer a vigorous endorsement of vaccinations as a measles outbreak worsened.(Reuters) Robert F. Kennedy Jr. announced in a statement Tuesday that 22 projects, totaling $500 million, to develop vaccines using mRNA technology will be halted. Kennedy's decision to terminate the projects is the latest in a string of decisions that have put the longtime vaccine critic's doubts about shots into full effect at the nation's health department. Kennedy has pulled back recommendations around the COVID-19 shots, fired the panel that makes vaccine recommendations, and refused to offer a vigorous endorsement of vaccinations as a measles outbreak worsened. The health secretary criticized mRNA vaccines in a video on his social media accounts, explaining the decision to cancel projects being led by the nation's leading pharmaceutical companies, including Pfizer and Moderna, that offer protection against viruses like the flu, COVID-19 and H5N1. 'To replace the troubled mRNA programs, we're prioritizing the development of safer, broader vaccine strategies, like whole-virus vaccines and novel platforms that don't collapse when viruses mutate," Kennedy said in the video. Infectious disease experts say the mRNA technology used in vaccines is safe, and they credit its development during the first Trump administration with slowing the 2020 coronavirus pandemic. Future pandemics, they warned, will be harder to stop without the help of mRNA. 'I don't think I've seen a more dangerous decision in public health in my 50 years in the business,' said Mike Osterholm, a University of Minnesota expert on infectious diseases and pandemic preparations. He noted mRNA technology offers potential advantages of rapid production, crucial in the event of a new pandemic that requires a new vaccine. The shelving of the mRNA projects is short-sighted as concerns about a bird flu pandemic continue to loom, said Dr. Paul Offit, a vaccine expert at Children's Hospital of Philadelphia. 'It's certainly saved millions of lives,' Offit said of the existing mRNA vaccines. Scientists are using mRNA for more than infectious disease vaccines, with researchers around the world exploring its use for cancer immunotherapies. At the White House earlier this year, billionaire tech entrepreneur Larry Ellison praised mRNA for its potential to treat cancer. Traditionally, vaccines have required growing pieces of viruses, often in chicken eggs or giant vats of cells, then purifying that material. The mRNA approach starts with a snippet of genetic code that carries instructions for making proteins. Scientists pick the protein to target, inject that blueprint and the body makes just enough to trigger immune protection — producing its own vaccine dose. In a statement Tuesday, HHS said 'other uses of mRNA technology within the department are not impacted by this announcement." The mRNA technology is used in approved COVID-19 and RSV shots, but has not yet been approved for a flu shot. Moderna, which was studying a combination COVID-19 and flu mRNA shot, had said it believed mRNA could speed up production of flu shots compared with traditional vaccines. The abandoned mRNA projects signal a 'shift in vaccine development priorities,' the health department said in its statement, adding that it will start 'investing in better solutions.' 'Let me be absolutely clear, HHS supports safe, effective vaccines for every American who wants them," Kennedy said in the statement. Speaking hours later Tuesday at a news conference in Anchorage, Alaska, alongside the state's two Republican U.S. senators, Kennedy said work is underway on an alternative. He said a 'universal vaccine' that mimics 'natural immunity" is the administration's focus. 'It could be effective — we believe it's going to be effective -- against not only coronaviruses, but also flu,' he said.
&w=3840&q=100)
First Post
15 hours ago
- First Post
Covid-style measures, drones and more... Inside China's efforts to battle Chikungunya outbreak
A chikungunya outbreak in southern China has infected over 7,000 people, triggering aggressive mosquito-control measures and hospital isolations. Originating in Foshan, the virus has spread across Guangdong province read more A female mosquito is seen on the forearm of a health technician in a laboratory at the entomology department of the Ministry of Public Health in Guatemala City, February 4, 2016. Representational Image/Reuters Southern China is currently witnessing an unprecedented spike in chikungunya virus cases, with over 7,000 infections recorded in a matter of weeks. The outbreak — originating in Foshan, a populous city in Guangdong province — has prompted public health measures, including both conventional mosquito-control strategies and unconventional methods rarely seen outside research settings. China has not experienced a chikungunya outbreak of this scale since the virus was first detected in the country nearly 20 years ago. STORY CONTINUES BELOW THIS AD Once a disease limited to sporadic imported cases, the chikungunya virus has now evolved into a pressing domestic health challenge. Though the virus is not directly transmissible from one person to another, the outbreak has escalated rapidly due to the region's environmental conditions, which are highly conducive to the proliferation of Aedes mosquitoes — the vector responsible for transmitting the disease. In Foshan alone, nearly 3,000 new cases were reported between July 27 and August 2, and infections have now appeared in several surrounding cities including Guangzhou, Shenzhen, Dongguan, and Zhongshan. What is Chikungunya? The chikungunya virus, first identified in 1952 in southern Tanzania, belongs to a family of viruses spread primarily through the bites of infected Aedes aegypti and Aedes albopictus mosquitoes. These same mosquito species are known carriers of other viruses such as dengue and Zika. Following an infectious bite, symptoms typically appear between four and eight days later. Most patients present with sudden fever, fatigue, muscle aches, and rashes. However, what distinguishes chikungunya from other mosquito-borne illnesses is the intense and persistent joint pain, often severe enough to leave patients bent over or stooped, a posture that inspired the name of the disease. The word 'chikungunya' comes from the Kimakonde language spoken in parts of Tanzania and means 'that which bends up.' According to the World Health Organisation (WHO), the virus typically resolves within two weeks, but in many cases, the associated joint pain can last for months — or even years — especially among the elderly and those with preexisting joint issues. STORY CONTINUES BELOW THIS AD While serious complications are rare and fatalities are extremely uncommon, the disease can be particularly dangerous for infants, senior citizens, and those with weakened immune systems. Chikungunya is not transmitted between humans. However, infected individuals can pass the virus back to mosquitoes if bitten again, creating a cycle that perpetuates local transmission. A June study published in Nature estimated that about 35.3 million people contract chikungunya annually across 180 countries and territories, though only about 3,700 deaths are linked to the virus worldwide each year. How did the outbreak occur in China? The current surge in southern China began with what health authorities believe was an imported case in Foshan in early July. Though the original source has not been publicly detailed, China's CDC attributes the outbreak to international transmission. 'With the virus spreading globally, imported cases have inevitably reached China,' Liu Qiyong, chief expert in vector-borne disease control at China CDC, told CGTN. 'Given the established presence of local transmission vectors, particularly Aedes mosquitoes, these imported infections have fuelled sustained local transmission cycles, leading to concentrated, small-scale outbreaks in affected regions.' The outbreak was initially concentrated in Shunde District, home to nearly 9 million residents, but quickly spread to nearby urban centres. STORY CONTINUES BELOW THIS AD On August 4, Hong Kong — China's semi-autonomous international hub — reported its first imported case, a 12-year-old boy who had recently visited Foshan. The scale and speed of the outbreak have led the US Centers for Disease Control and Prevention (CDC) to issue a Level 2 travel alert for Foshan, advising travellers to take protective measures such as using insect repellent, wearing long-sleeved clothing, and avoiding outdoor exposure during peak mosquito activity times. Pregnant women are specifically advised not to travel to the affected region. How is China tackling the chikungunya outbreak? Faced with rising infections, authorities in Guangdong have introduced a stringent set of disease-control protocols, drawing heavily on the infrastructure and response mechanisms developed during the Covid-19 pandemic. Patients who test positive for chikungunya are being quarantined in mosquito-proof hospital beds until they test negative, a precautionary step aimed at stopping further mosquito-mediated transmission. The city of Foshan has expanded its mosquito-proof isolation bed capacity to more than 7,000, according to Xinhua, China's state-run media. Designated hospitals across the region are offering treatment, although there is no specific antiviral drug or cure for chikungunya — management largely consists of symptom relief and supportive care. STORY CONTINUES BELOW THIS AD In affected neighbourhoods, local health workers are conducting door-to-door inspections, looking for stagnant water sources, which are prime breeding grounds for mosquitoes. Residents are expected to comply, and failure to cooperate may result in fines or criminal penalties under public health laws. In one district in Guicheng, five households reportedly had their electricity cut off for obstructing inspection efforts, according to a neighbourhood committee notice cited by the New York Times. A government flyer translated by the same publication warned that obstructing vector-control measures could be prosecuted as a criminal offence under laws pertaining to the prevention of infectious diseases. Beyond traditional mosquito control efforts like spraying pesticides and using insecticides, authorities have also turned to more experimental and ecologically-based interventions. One such method involves releasing 'elephant mosquitoes' — a type of mosquito that does not bite humans but whose larvae prey on the larvae of disease-carrying Aedes mosquitoes. In some urban lakes and ponds, officials have introduced larvae-eating fish, hoping to reduce mosquito populations in standing water bodies. STORY CONTINUES BELOW THIS AD Drones have been deployed to identify mosquito breeding grounds in hard-to-access areas, and specialised teams have been dispatched to fog and disinfect entire neighbourhoods. These combined efforts aim to interrupt the mosquito life cycle at various stages — larvae, pupae, and adult — to reduce the probability of additional infections. Did climate change play a role? Southern China's humid subtropical climate, combined with high population density and global connectivity, makes it particularly vulnerable to imported mosquito-borne diseases. The increased volume of international travel — especially as countries reopened post-Covid — has elevated the risk of pathogens moving across borders. From 2010 to 2019, China recorded only sporadic imported cases of chikungunya, including localized clusters in Dongguan and Ruili. Unlike previous instances where the virus did not take hold in the domestic mosquito population, this time conditions seem to have favoured local transmission chains. The WHO has long warned of the expanding range of Aedes mosquitoes due to urbanisation and climate change. As temperatures rise and rainfall patterns shift, mosquito habitats are spreading into previously low-risk areas, making outbreaks like the one in Foshan more likely. STORY CONTINUES BELOW THIS AD Why is chikungunya a global problem? Chikungunya is a recurring problem in many parts of the world. Brazil, Colombia, India, Mexico, Nigeria, Pakistan, Thailand, and the Philippines are among the countries where the CDC has identified an elevated risk of transmission. In 2006, India experienced a significant outbreak, recording nearly 1.3 million suspected infections, especially in Karnataka and Maharashtra. Around the same time, Sri Lanka, Singapore, and Thailand also reported thousands of cases. The US has also seen a growing number of travel-related chikungunya cases. Between 2006 and 2013, up to 28 cases were detected annually. In 2014, that number jumped to nearly 3,000. While the figures declined in subsequent years — reaching a low of 36 in 2021 — they have been gradually rising again, with 199 cases reported in 2024 and 46 recorded so far in 2025. Local transmission was last documented in 2019, and the CDC considers the risk of widespread outbreaks in the US to be low, though not negligible. As of May this year, La Réunion, a French overseas territory in the Indian Ocean, has reported over 47,500 chikungunya cases, with sustained transmission across the island. What is the cure to chikungunya? Two vaccines against chikungunya are currently approved for use in the United States: IXCHIQ , a live-attenuated vaccine for individuals aged 18 and older. VIMKUNYA, a virus-like particle-based vaccine for people aged 12 and above. However, these vaccines are not yet available in China. The country's health authorities continue to highlight preventive strategies such as eliminating mosquito breeding sites and using physical barriers like mosquito nets, repellents, and protective clothing. STORY CONTINUES BELOW THIS AD While vaccination is advised for international travellers to outbreak-prone areas, including Foshan, it is not currently recommended for widespread use among the general population in China. The US CDC also advises that pregnant women postpone vaccination until after childbirth and consider postponing travel to high-risk regions altogether. With inputs from agencies
